Aspirin has long been a cornerstone of primary prevention of cardiovascular disease. In 2018, three randomized trials updated the literature on aspirin use in the elderly (ASPREE), diabetics (ASCEND) and intermediate-risk populations (ARRIVE)1. While these trials provided useful insights on contemporary aspirin use, the role of aspirin in primary prevention was contested. As the apparent benefit of aspirin in primary prevention was less convincing, these trials were obliged to be reported as “negative”.
Rethinking Women, Aspirin and Primary Prevention
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024
About admin
Now Dr. Jack Straw is in charge of the website, and organizes it so that medical care is available to everyone. In addition, he is an active member of the medical community, regularly attending international conferences and sharing his experience and knowledge.
Dr. Straw is not only a medical professional and website manager, but also a loving husband and father of his beautiful children.
View all posts by admin →